Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism

International Journal of Cancer

Volumn 100, Issue 1, 2002, Pages 111-118

  Feleszko, Wojciech ^a,b   Młynarczuk, Izabela ^a   Olszewska, Dominika ^a   Jalili, Ahmad ^a   Grzela, Tomasz ^a,b   Lasek, Witold ^a   Hoser, Grazyna ^c   Korczak Kowalska, Grazyna ^b,d   Jakóbisiak, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^d UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apoptosis; Chemoprevention; Doxorubicin; Lovastatin; Melanoma; Tumor therapy

Indexed keywords

DOXORUBICIN; MEVINOLIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG POTENTIATION; ISCHEMIC HEART DISEASE; MELANOMA; MELANOMA CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TREATMENT PLANNING;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; DOXORUBICIN; DRUG SYNERGISM; FEMALE; HUMANS; IN SITU NICK-END LABELING; LOVASTATIN; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 0036643517     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10440     Document Type: Article

References (37)

1. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
2. Current perspectives on statins
3. Inhibitors of Ras farnesyltransferases
4. Protein prenylation: A mediator of protein-protein interactions
5. Inhibition of cell growth by lovastatin is independent of ras function
6. Cell cycle-specific effects of lovastatin
7. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3
8. Lovastatin induces apoptosis in malignant mesothelioma cells
9. Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin
10. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells
11. Inhibition of pancreatic adenocarcinoma cell growth by lovastatin
12. Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis
13. Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma
14. Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice
15. Lovastatin and TNF-α exhibit potentiated antitumor effects against Ha-ras transformed murine tumor via inhibition of tumor-induced angiogenesis
16. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice
17. Novel Ras antagonist blocks human melanoma growth
18. Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy
19. Tourniquet infusion chemotherapy for extremity in-transit lesions in malignant melanoma
20. Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: Phase II studies by the Eastern Cooperative Oncology Group
21. Re: Greying of America will foster new strategies in oncology
22. Phase I study of lovastatin, an inhibitor of the mevalonate pathway in patients with cancer
23. A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme
24. Quantitation of synergism and antagonism of 2 or more drugs by computerized analysis
25. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
26. In vivo methods for screening and preclinical testing
27. Specific proteolytic cleavage of poly (ADP-ribose)polymerase: An early marker of chemotherapy-induced apoptosis
28. Effects of lovastatin on a human myeloma cell line: Increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein
29. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P-glycoprotein-expressing cells
30. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth
31. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells
32. Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer
33. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells
34. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effect of sulindac
35. In vitro antitumor activity of cerivastatin a novel and potent HMG-CoA reductase inhibitor
36. Growth in use of statins after trials is not targeted to most appropriate patients